NCT00811863View on ClinicalTrials.gov

Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

February 28, 2009

Primary Completion Date

May 17, 2012

Study Completion Date

May 17, 2012

Conditions
Nephrogenic Systemic FibrosisRenal Insufficiency
Trial Locations (1)

44512

Radiology Consultants, Inc., Youngstown

Sponsors

Lead Sponsor

Guerbet
All Listed Sponsors
lead

Guerbet

INDUSTRY

NCT00811863 - Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection | Biotech Hunter | Biotech Hunter